Table 4.
Prevalence of primary graft dysfunction after lung transplantation
| Overall (N = 112) | Bridge-ECMO group (n = 27) | Non-bridge-ECMO group (n = 85) | p | |
|---|---|---|---|---|
| 0 h | 0.255 | |||
| PGD 0 | 89 (79.5%) | 25 (92.6%) | 64 (75.3%) | |
| PGD 1 | 1 (0.9%) | 0 (0.0%) | 1 (1.2%) | |
| PGD 2 | 6 (5.4%) | 1 (3.7%) | 5 (5.9%) | |
| PGD 3 | 16 (14.3%) | 1 (3.7%) | 15 (17.6%) | |
| 24 h | 0.481 | |||
| PGD 0 | 96 (85.7%) | 25 (92.6%) | 71 (83.5%) | |
| PGD 1 | 5 (4.5%) | 1 (3.7%) | 4 (4.7%) | |
| PGD 2 | 4 (3.6%) | 1 (3.7%) | 3 (3.5%) | |
| PGD 3 | 7 (6.2%) | 0 (0.0%) | 7 (8.2%) | |
| 48 h | 0.817 | |||
| PGD 0 | 99 (88.4%) | 25 (92.6%) | 74 (87.1%) | |
| PGD 1 | 5 (4.5%) | 1 (3.7%) | 4 (4.7%) | |
| PGD 2 | 6 (5.4%) | 1 (3.7%) | 5 (5.9%) | |
| PGD 3 | 2 (1.8%) | 0 (0.0%) | 2 (2.4%) | |
| 72 h | 0.561 | |||
| PGD 0 | 99 (88.4%) | 25 (92.6%) | 74 (87.1%) | |
| PGD 1 | 4 (3.6%) | 0 (0.0%) | 4 (4.7%) | |
| PGD 2 | 7 (6.2%) | 2 (7.4%) | 5 (5.9%) | |
| PGD 3 | 2 (1.8%) | 0 (0.0%) | 2 (2.4%) |
ECMO extracorporeal membrane oxygenation, PGD primary graft dysfunction